By David Wallace 26 Feb 2021
Viatris’ Mylan has received a positive opinion from the EMA’s CHMP for its bevacizumab biosimilar rival to Avastin under two...
Access your global breakdown of the top companies of the past 12 months.
You’ll see which companies came out on top and which saw their place slip, as leading organizations are ranked. The league board is based on analysis of annual sales data reported by each company with sales broken down by:
By Dean Rudge 25 Feb 2021
Coherus BioSciences is aiming to translate the success of its comprehensive biosimilar pegfilgrastim strategy to adalimumab, with plans to capture...
By David Wallace 23 Feb 2021
Medicines for Europe has called for fresh efforts to bolster the value added medicines sector and “level the playing field”...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: